Breast Cancer Risk Biomarkers in Postmenopausal Women

Summary

This study is designed to gather information on how the prescription drug Lovaza™ which contains omega-3 fatty acids, affects blood and tissue risk biomarkers for breast cancer. This drug is currently approved by the FDA for reducing blood levels of triglycerides.

Timeline

Start

2010-11

Primary completion

2013-05

Completion

2013-05

Drugs

Indications